Science Explorer Back to mapMap
Discussion
Researcher · Rigshospitalet · Denmark

Mikael Rahbek Rørth

Mikael Rahbek Rørth publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Testicular diseases and treatments, Cancer survivorship and care and Sperm and Testicular Function.

OpenAlex
World rank
#227,043
of 7,710,434 ranked researchers
Rank in Denmark
#1,516
of 43,819
Works
242
Citations
9.7k
Citations per work
40.1
h-index
55
i10-index 146Top 2.9% in Oncology
Mikael Rahbek Rørth

What does Mikael Rahbek Rørth research?

Mikael Rahbek Rørth's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 128 works · 53.0% of their workMedicine: 128 works · 53.0% of their workOncology: 41 works · 17.1% of their workSurgery: 37 works · 15.3% of their workPulmonary and Respiratory Medicine: 26 works · 10.8% of their workReproductive Medicine: 15 works · 6.0% of their workPhysiology: 9 works · 3.8% of their workEverything else: 98 works · 40.7% of their workLife Sciences: 15 works · 6.3% of their workBiochemistry, Genetics and Molecular Biology: 15 works · 6.3% of their workMolecular Biology: 15 works · 6.3% of their workTHEIR WORKMikael RahbekRørth242works
Life Sciences6%Health Sciences53%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine12853.0%
  2. Everything else9840.7%
    1. Biochemistry, Genetics and Molecular Biology156.3%
  1. 1Oncology17% of their works
  2. 2Surgery15% of their works
  3. 3Pulmonary and Respiratory Medicine11% of their works
  4. 4Molecular Biology6% of their works
  5. 5Reproductive Medicine6% of their works
  6. 6Physiology4% of their works

Research topics

Which keywords describe Mikael Rahbek Rørth's research?

The keywords of their largest research topics: Chemotherapy, Germ Cell Tumors, Testicular Cancer, Cancer Survivorship, Quality of Life, Immunotherapy, Clinical Trials and Targeted Therapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Chemotherapy1063 topics
  2. Germ Cell Tumors771 topic
  3. Testicular Cancer771 topic
  4. Cancer Survivorship461 topic
  5. Quality of Life461 topic
  6. Immunotherapy332 topics
  7. Clinical Trials322 topics
  8. Targeted Therapy322 topics
  9. Oxidative Stress261 topic
  10. Sperm DNA Fragmentation261 topic
  11. Congenital Adrenal Hyperplasia191 topic
  12. Steroid 21-Hydroxylase Deficiency191 topic
  13. ALK171 topic
  14. Neuroblastoma171 topic
  15. ALK Inhibitors161 topic
  16. EGFR Mutations161 topic
  17. Genomic Profiles161 topic
  18. Small-Cell Lung Cancer161 topic
  19. Breast Cancer131 topic
  20. Cognitive Function131 topic

Where does Mikael Rahbek Rørth work?

Mikael Rahbek Rørth's main affiliation in the publication record is Rigshospitalet, Denmark.

How many publications and citations does Mikael Rahbek Rørth have?

OpenAlex counts 242 works and 9,711 citations for Mikael Rahbek Rørth, an h-index of 55, ranking #227,043 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mikael Rahbek Rørth. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.